Virtual diabetes programs aim to prove themselves to insurers | Modern Healthcare
Published August 11, 2024
You’re seeing the reaction to these solutions from payers that are saying, ‘It’s not getting engagement, I'm paying all this money, I'm not getting no return on investment for it.’
CareFirst, Ryse Health Value-Based Care Partnership Yields Unprecedented Results for Type II Diabetes Patients
Published July 16, 2024
The results from the first year of our partnership show that this hybrid method of diabetes care does support better health outcomes and we look forward to making it available to additional members in the months and years to come.
Local startup looks to diagnose and treat flaws in diabetes care
Published October 23, 2023
Ryse Health pairs patients with an endocrinologist, a diabetes care specialist, a health coach and a behavioral health specialist. Via chat, email, video and in-person visits, they provide regular support, tips for managing diabetes and coaching, while connecting patients with diabetic peers.
CareFirst, Ryse Health partner to take on uncontrolled Type 2 diabetes
By Frank DiamondAug 14, 2023
CareFirst BlueCross BlueShield is joining forces with Ryse Health, a company that specializes in providing in-person and virtual care for patients with uncontrolled Type 2 diabetes, in hopes of driving better long-term outcomes.
CareFirst officials said they believe the effort will help improve care by better pinpointing what they need most.
A Patient-Centered Approach to Type2 Diabetes Care
Aug 8, 2023 | 1501 Health
Chronic disease, cardiometabolic health in particular, is a massive problem in the United States—significantly impacting many lives in a negative way, leading to millions of deaths every year and costing nearly a trillion dollars.
It's clear there's an approach that could deliver better outcomes than the status quo of care, and Ryse Health, based in Maryland and DC and led by Richard Gurley, is providing it.
Exclusive: Ryse Health draws $6.5M Series A for hybrid diabetes care
Erin Brodwin , author of Axios Pro: Health Tech Deals
Diabetes Care provider Ryse Health drew $6.5 million in Series A funds for its virtual and in-person services, CEO Richard Gurley tells Axios exclusively.
Diabetes Care provider Ryse Health drew $6.5 million in Series A funds for its virtual and in-person services, CEO Richard Gurley tells Axios exclusively.
Why I Co-Founded Ryse Health
Published May 24, 2022
When I was leaving WelbeHealth, I was intent on being thoughtful about my next full-time role. I told my wife, “I don’t know if I’ll end up at a 4-person company or a 40,000-person company, but the one thing I know I won’t do is start my own company.” And yet, here I am: co-founder of Ryse Health, a new startup helping patients manage type 2 diabetes and other chronic diseases. The obvious question that springs from that epic flip flop is “Why?”
